Target intelligence / Profile preview

Voltage-dependent anion channel 1 pseudogene 12 (VDAC1P12)

Target
VDAC1P12
01

Overview

VDAC1P12 refers to a pseudogene of the voltage-dependent anion channel 1 gene (VDAC1). The canonical/functional form, VDAC1, encodes a mitochondrial outer membrane protein important in metabolite transport, energy metabolism, apoptosis, and is implicated in tumorigenesis and cancer therapy development[1][2]. However, VDAC1P12 is not a protein-coding gene but a pseudogene—meaning it is a genomic remnant with high sequence similarity to VDAC1 but lacking the ability to produce a functional protein product. Pseudogenes do not encode active targets, are not enzymes, receptors, channels, or transporters, and thus are not considered therapeutic targets. There are no aliases in use other than referencing it as a pseudogene. There is nothing in the literature suggesting VDAC1P12 has biological function, disease association, or utility in drug development, biomarker assessment, or clinical targeting. If your intent was an active drug target, the correct entry is Voltage-dependent anion channel 1 (VDAC1). VDAC1P12, as a pseudogene, should not be considered a druggable target.

Other names
VDAC1 pseudogene 12VDAC1P12

Beyond the preview

Go deeper on Voltage-dependent anion channel 1 pseudogene 12 (VDAC1P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion channel 1 pseudogene 12 (VDAC1P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call